A Study of Donepezil Hydrochloride in Patients With Dementia Associated With Cerebrovascular Disease

Summary

The primary objectives are to confirm that donepezil hydrochloride has superior efficacy compared with placebo in improving cognitive function, as measured by Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-cog), and to demonstrate that donepezil hydrochloride has superior efficacy compared with placebo in improving global function, as measured by Clinician's Interview-Based Impression of Change-plus Caregiver Input (CIBIC-plus), in patients with dementia associated with cerebrovascular disease (VaD).

Timeline

Start

2013-08-05

Primary completion

2018-07-13

Completion

2018-12-21

Drugs

Indications